Akero Therapeutics, Inc.: SCHEDULE 13G/A filed Feb 17, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 17, 2026

Accession number

0001493215-26-000022

Filer

Akero Therapeutics, Inc. (CIK 1744659)